Discover 1,583 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,583
Active & Responsive
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
for
Chronic Kidney Diseases, End Stage Renal Disease,
Location: Raleigh NC, Charlotte NC, Florence SC, Columbia SC,
Sponsor: VenoStent
Sex: All
Age: 18+
Code: NCT06001827
Recruiting
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: Raleigh NC, Burlington NC, Charleston SC, York PA,
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
for
End Stage Renal Disease (ESRD), Kidney Failure,
Location: Raleigh NC, Durham NC, Charlotte NC, Orangeburg SC,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18 - 70+
Code: NCT04671771
Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Raleigh NC, Lynchburg VA, Charlotte NC, Asheville NC,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Raleigh NC, Wilmington NC, Morehead City NC,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: Raleigh NC, Richmond VA, Fairfax VA, Acworth GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
for
Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU)
Location: Raleigh NC, Cary NC, Salem VA, Blue Ash OH, Boardman OH,